At 8.6% CAGR, the Asia Pacific Sterilization Services Market is Projected to be Worth US$ 1,316.89 Million by 2030, Says Business Market Insights

According to Business Market Insights research, the Asia Pacific sterilization services market was valued at US$ 682.94 in 2022 and is expected to reach US$ 1,316.89 million by 2030, registering a CAGR of 8.6% from 2022 to 2030. Growing number of surgical procedures and growing medical device industry are among the critical factors attributed to the Asia Pacific sterilization services market expansion.

Surgical care is essential for treating diverse health conditions such as injuries, malignancy, infections, and cardiovascular diseases. Most medical and surgical devices used in healthcare facilities need to be sterilized to avoid life-threatening infections. As per an article published in 2020 by John Wiley & Sons, Inc., globally over 313 million patients undergo surgical procedures yearly. An increasing number of surgeries and hospital-associated infections are facilitating the importance of sterilization services in the healthcare domain. The most common surgical procedures include cesarean, orthopedic processes (hip and knee replacement), neurosurgical procedures, and intra-abdominal procedures. Increasing road fatalities and congenital disabilities have also intensified the number of surgeries performed worldwide. Medical devices that come into contact with body tissues or fluids and instrument items, including surgical instruments, biopsy forceps, and implanted medical devices, are considered critical. These items should be sterile when used, as microbial contamination could result in disease transmission. Thus, the increasing number of surgeries is driving the sterilization services market.

On the contrary, stringent regulation regarding chemical emission hamper the growth Asia Pacific sterilization services market .

Based on mode of delivery, the Asia Pacific sterilization services market is bifurcated into offsite sterilization services market and onsite sterilization services market. The offsite sterilization services market segment held 59.2% share of the Asia Pacific sterilization services market in 2022, amassing US$ 404.21 million. It is projected to garner US$ 768.60 million by 2030 to expand at 8.4% CAGR during 2022-2030.

By method, the Asia Pacific sterilization services market is segmented into ethylene oxide, chlorine dioxide, gamma ray, electron beam, autoclave steam, and others. The ethylene oxide market segment held 31.1% share of the Asia Pacific sterilization services market in 2022, amassing US$ 212.27 million. It is projected to garner US$ 395.32 million by 2030 to expand at 8.1% CAGR during 2022-2030.

In terms of service type, the Asia Pacific sterilization services market is categorized into contract sterilization and microbial reduction services, testing and validation services, equipment, and others. The contract sterilization and microbial reduction services segment held 40.7% share of the Asia Pacific sterilization services market in 2022, amassing US$ 277.72 million. It is projected to garner US$ 554.35 million by 2030 to expand at 9.0% CAGR during 2022-2030.

By end user, the Asia Pacific sterilization services market is segmented into medical device companies, pharmaceutical and biopharmaceutical companies, food and beverage, hospitals and clinics, and others. The medical device companies segment held 45.8% share of Asia Pacific sterilization services market in 2022, amassing US$ 312.67 million. It is projected to garner US$ 623.87 million by 2030 to expand at 9.0% CAGR during 2022-2030.

Based on country, the Asia Pacific sterilization services market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China held 29.9% share of Asia Pacific sterilization services market in 2022, amassing US$ 204.36 million. It is projected to garner US$ 409.26 million by 2030 to expand at 9.1% CAGR during 2022-2030.

Key players operating in the Asia Pacific sterilization services market are China Biotech Corporation, Microtrol Sterilisation Services Pvt Ltd, Sotera Health Company, and Steris Plc, among others.

- In June 2021, Steris Plc. acquired Cantel Medical, a global provider of infection prevention products and services to endoscopy, dental, dialysis and life sciences customers. The acquisition will leverage the expertise of the company to provide a more extensive and innovative suite of product offerings to the customers around the world.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com